Koate B B D, Buseri F I, Jeremiah Z A
Department of Medical Laboratory Sciences, Rivers State University of Science & Technology, Nkpolu-Oroworukwo, Port Harcourt, Nigeria.
Transfus Med. 2005 Oct;15(5):449-51. doi: 10.1111/j.1365-3148.2005.00601.x.
Anti-HCV pre-transfusion testing among blood donors has not been introduced as a mandatory test in Rivers State, hence the risk of transfusion-transmitted HCV cannot be fully ascertained. One thousand (1000) apparently healthy blood donors were screened using a rapid second - generation test, the HEP C SPOT HCV assay. An overall prevalence of 2.9% was observed in this study. The highest prevalence (8.1%) was found among adults aged between 26 and 33 years and commercial donors.
在河流州,尚未将献血者抗丙型肝炎病毒输血前检测作为强制检测项目,因此输血传播丙型肝炎病毒的风险无法完全确定。使用快速第二代检测方法——丙型肝炎病毒斑点检测法对1000名表面健康的献血者进行了筛查。本研究观察到总体患病率为2.9%。在年龄介于26至33岁的成年人及商业献血者中发现了最高患病率(8.1%)。